Literature DB >> 18390990

Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ.

Isabelle Castan-Laurell1, Michaela Vítkova, Danièle Daviaud, Cédric Dray, Michaela Kováciková, Zuzana Kovacova, Jindriska Hejnova, Vladimir Stich, Philippe Valet.   

Abstract

OBJECTIVE: Apelin is a novel adipokine acting on APJ receptor, regulated by insulin and tumor necrosis factor-alpha (TNF-alpha) in adipose tissue (AT). Plasma apelin levels are increased in obese hyperinsulinemic subjects. The aim was to investigate whether the hypocaloric diet associated with weight loss modifies the elevated plasma apelin levels and the expression of apelin and APJ receptor in AT in obese women. DESIGN AND METHODS: Fasting plasma levels of apelin and TNF-alpha as well as mRNA levels of apelin and APJ in AT were measured before and after a 12-week hypocaloric weight-reducing diet in 20 obese women (body mass index (BMI) before diet 32.2+/-6.4 kg/m(2)). Twelve healthy women with a BMI of 20.7+/-0.6 kg/m(2) served as reference.
RESULTS: Plasma levels of apelin and TNF-alpha were higher in obese compared with lean controls. The hypocaloric diet resulted in a significant decrease of BMI to 29.8+/-6.3 kg/m(2), plasma insulin (8.16+/-0.73 to 6.58+/-0.66 mU/l), apelin (369+/-25 pg/ml to 257+/-12 pg/ml), TNF-alpha levels (0.66+/-0.04 pg/ml to 0.56+/-0.04 pg/ml), and AT mRNAs of apelin and APJ. In addition, changes in AT mRNA apelin were related to changes in AT mRNA APJ levels.
CONCLUSION: The hypocaloric diet associated with weight loss reduces the increased plasma and AT expression of apelin in obese women. This reduced apelin expression in AT could contribute to decreased circulating apelin levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18390990      PMCID: PMC2683032          DOI: 10.1530/EJE-08-0039

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  16 in total

1.  Apelin, a novel adipokine over-produced in obesity: friend or foe?

Authors:  Isabelle Castan-Laurell; Jérémie Boucher; Cédric Dray; Danièle Daviaud; Charlotte Guigné; Philippe Valet
Journal:  Mol Cell Endocrinol       Date:  2005-11-18       Impact factor: 4.102

2.  TNFalpha up-regulates apelin expression in human and mouse adipose tissue.

Authors:  Danièle Daviaud; Jérémie Boucher; Stéphane Gesta; Cédric Dray; Charlotte Guigne; Didier Quilliot; Ahmet Ayav; Olivier Ziegler; Christian Carpene; Jean-Sébastien Saulnier-Blache; Philippe Valet; Isabelle Castan-Laurell
Journal:  FASEB J       Date:  2006-05-24       Impact factor: 5.191

3.  Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.

Authors:  L Li; G Yang; Q Li; Y Tang; M Yang; H Yang; K Li
Journal:  Exp Clin Endocrinol Diabetes       Date:  2006-11       Impact factor: 2.949

Review 4.  Apelin and visfatin: unique "beneficial" adipokines upregulated in obesity?

Authors:  Jerzy Bełtowski
Journal:  Med Sci Monit       Date:  2006-05-29

5.  Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-angiotensin type 1 receptor system.

Authors:  Yoshitaka Iwanaga; Yasuki Kihara; Hiroyuki Takenaka; Toru Kita
Journal:  J Mol Cell Cardiol       Date:  2006-08-17       Impact factor: 5.000

6.  Apelin and its receptor are expressed in human osteoblasts.

Authors:  Hui Xie; Si-yuan Tang; Rong-rong Cui; Jiao Huang; Xiao-hong Ren; Ling-qing Yuan; Ying Lu; Min Yang; Hou-de Zhou; Xian-ping Wu; Xiang-hang Luo; Er-yuan Liao
Journal:  Regul Pept       Date:  2006-03-06

Review 7.  Apelin signalling: a promising pathway from cloning to pharmacology.

Authors:  B Masri; B Knibiehler; Y Audigier
Journal:  Cell Signal       Date:  2005-04       Impact factor: 4.315

8.  Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.

Authors:  K Tatemoto; M Hosoya; Y Habata; R Fujii; T Kakegawa; M X Zou; Y Kawamata; S Fukusumi; S Hinuma; C Kitada; T Kurokawa; H Onda; M Fujino
Journal:  Biochem Biophys Res Commun       Date:  1998-10-20       Impact factor: 3.575

9.  Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release.

Authors:  Nadia De Mota; Annabelle Reaux-Le Goazigo; Said El Messari; Nicolas Chartrel; Darren Roesch; Cynthia Dujardin; Claude Kordon; Hubert Vaudry; Françoise Moos; Catherine Llorens-Cortes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-01       Impact factor: 11.205

10.  Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression.

Authors:  Pavan Atluri; Kevin J Morine; George P Liao; Corinna M Panlilio; Mark F Berry; Vivian M Hsu; William Hiesinger; Jeffrey E Cohen; Y Joseph Woo
Journal:  Cell Mol Biol Lett       Date:  2006-11-19       Impact factor: 5.787

View more
  39 in total

Review 1.  Apelin and insulin resistance: another arrow for the quiver?

Authors:  Shiming Xu; Philip S Tsao; Patrick Yue
Journal:  J Diabetes       Date:  2011-09       Impact factor: 4.006

2.  Apelin Reduces Nitric Oxide-Induced Relaxation of Cerebral Arteries by Inhibiting Activation of Large-Conductance, Calcium-Activated K Channels.

Authors:  Amreen Mughal; Chengwen Sun; Stephen T OʼRourke
Journal:  J Cardiovasc Pharmacol       Date:  2018-04       Impact factor: 3.105

3.  Plasma Apelin Unchanged With Acute Exercise Insulin Sensitization.

Authors:  Justin D Waller; Emily H McNeill; Frank Zhong; Lauren S Vervaecke; Allan H Goldfarb
Journal:  J Sports Sci Med       Date:  2019-08-01       Impact factor: 2.988

Review 4.  Adipose tissue and vascular inflammation in coronary artery disease.

Authors:  Enrica Golia; Giuseppe Limongelli; Francesco Natale; Fabio Fimiani; Valeria Maddaloni; Pina Elvira Russo; Lucia Riegler; Renatomaria Bianchi; Mario Crisci; Gaetano Di Palma; Paolo Golino; Maria Giovanna Russo; Raffaele Calabrò; Paolo Calabrò
Journal:  World J Cardiol       Date:  2014-07-26

5.  Apelin is a novel regulator of human trophoblast amino acid transport.

Authors:  O R Vaughan; T L Powell; T Jansson
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-03-05       Impact factor: 4.310

Review 6.  Apelin, diabetes, and obesity.

Authors:  Isabelle Castan-Laurell; Cédric Dray; Camille Attané; Thibaut Duparc; Claude Knauf; Philippe Valet
Journal:  Endocrine       Date:  2011-08       Impact factor: 3.633

7.  Effect of Spironolactone on Plasma Apelin-12 Levels in Patients with Chronic Systolic Heart Failure.

Authors:  Mustafa Topuz; Mehmet Cosgun; Oğuz Akkuş; Atilla Bulut; Omer Sen; Ayşe Nur Topuz; Murat Caylı
Journal:  Acta Cardiol Sin       Date:  2016-11       Impact factor: 2.672

8.  Acute and chronic effects of biliopancreatic diversion with duodenal switch surgery on plasma visfatin and apelin levels in patients with severe obesity.

Authors:  Sarah-Maude Caron-Cantin; Julie Martin; Marjorie Bastien; Mercedes Nancy Munkonda; Huiling Lu; Katherine Cianflone; Fady Moustarah; Laurent Biertho; Simon Marceau; Frédéric-Simon Hould; Jean Bussières; Paul Poirier
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

9.  Increased bone mass in mice lacking the adipokine apelin.

Authors:  Lalita Wattanachanya; Wei-Dar Lu; Ramendra K Kundu; Liping Wang; Marcia J Abbott; Dylan O'Carroll; Thomas Quertermous; Robert A Nissenson
Journal:  Endocrinology       Date:  2013-04-12       Impact factor: 4.736

10.  Apelin attenuates oxidative stress in human adipocytes.

Authors:  Aung Than; Xiaohong Zhang; Melvin Khee-Shing Leow; Chueh Loo Poh; Seow Khoon Chong; Peng Chen
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.